AllNews'Cofepris' - 4 News Result(s)Mexico Grants Authorisation For Emergency Use Of India's Covaxin VaccineIndia News | ANI | Wednesday April 7, 2021 The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin. www.ndtv.comWorld's First Anti-Dengue Vaccine Brings Hope For IndiaHealth | Indo-Asian News Service | Thursday December 10, 2015 At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus. www.ndtv.comBiocon Jumps on Approval for Insulin in MexicoBusiness | Friday April 10, 2015 Company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement. www.ndtv.com/businessBiocon gets Approval for Insulin Glargine in MexicoBusiness | Thursday April 9, 2015 The company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement. www.ndtv.com/business'Cofepris' - 4 News Result(s)Mexico Grants Authorisation For Emergency Use Of India's Covaxin VaccineIndia News | ANI | Wednesday April 7, 2021 The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin. www.ndtv.comWorld's First Anti-Dengue Vaccine Brings Hope For IndiaHealth | Indo-Asian News Service | Thursday December 10, 2015 At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus. www.ndtv.comBiocon Jumps on Approval for Insulin in MexicoBusiness | Friday April 10, 2015 Company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement. www.ndtv.com/businessBiocon gets Approval for Insulin Glargine in MexicoBusiness | Thursday April 9, 2015 The company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement. www.ndtv.com/businessYour search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com